Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma

Gut

Volumn 48, Issue 1, 2001, Pages 87-96

  Von Marschall, Z ^a   Cramer, T ^a   Hocker M ^a   Finkenzeller, G ^b   Wiedenmann, B ^a   Rosewicz, S ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiogenesis; Hepatocellular carcinoma; Hypoxia; Vascular endothelial growth factor

Indexed keywords

FETAL LIVER KINASE 1; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1;

ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HALF-LIFE; HUMANS; IN SITU HYBRIDIZATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; LUCIFERASES; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035164117     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.1.87     Document Type: Article

References (53)

1. Induction of angiogenesis during the transition from hyperplasia to neoplasia
2. Angiogenesis in cancer, vascular, rheumatoid and other disease
3. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
4. Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis
5. The regulation of blood vessel growth by vascular endothelial growth factor
6. The role of vascular endothelial growth factor in pathological angiogenesis
7. Regulation of the expression of the VEGF/VPS and its receptors: Role in tumour angiogenesis
8. Vascular endothelial growth factor is a secreted angiogenic mitogen
9. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
10. The human gene for vascular endothelial growth factor
11. 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
12. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
13. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
14. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
15. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoetic cells and exhibiting close genetic linkage to c-kit
16. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
17. Differential expression of the two VEGF receptors fit and KDR in placenta and vascular endothelial cells
18. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development
19. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
20. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor
21. Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase
22. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
23. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
24. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
25. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
26. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumour growth, and its inhibition by the antibody
27. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
28. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
29. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumour types in vivo
30. Hepatocellular carcinoma. A worldwide problem and the major risk factors
31. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
32. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma
33. Expression of vascular endothelial growth factor in human hepatocellular carcinoma
34. Increased expression of vascular endothelial growth factor is associated with tumour progression in hepatocellular carcinoma
35. Glucocorticoid receptor gene expression in the exocrine and endocrine rat pancreas
36. Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR
37. Clinical signification of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumour
38. KDR/flk-1 is a major regulator of vascular endothelial growth factor-induced tumour development and angiogenesis in murine hepatocellular carcinoma cells
39. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human HCC
40. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma
41. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
42. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
43. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
44. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
45. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
46. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
47. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
48. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
49. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability
50. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
51. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implication for translation under hypoxia
52. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α-subunit
53. Hypoxia-inducible factor 1a (HIF1-α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions